Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mezzion Pharma (140410 KS)
Watchlist
21
Analysis
Health Care
•
South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
01 Nov 2023 07:00
KRX Short Interest Weekly (Oct 27th): Samsung Biologic, Skc, Hotel Shilla Co, Ecopro
We analyzed KRX short interest report for the past week and highlight short interest changes in Samsung Biologic, Skc, Hotel Shilla Co, Ecopro,...
Ke Yan, CFA, FRM
Follow
444 Views
Share
bullish
•
SK Biopharmaceuticals
•
02 Jul 2020 00:03
Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing
Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...
Ken S. Kim
Follow
502 Views
Share
bullish
•
Quantitative Analysis
•
15 Apr 2020 05:39
Biotech & Pharma Moving Up As Short Covering Continues
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 10 April 2020, the...
Brian Freitas
Follow
547 Views
Share
bullish
•
Quantitative Analysis
•
29 Jan 2020 17:47
Korea - Pharma Stocks See Short Covering
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 23 January...
Brian Freitas
Follow
572 Views
Share
bearish
•
Quantitative Analysis
•
16 Oct 2019 06:41
Korea - The Shorts Must Be Crazy (On Some Names)!
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 11 October.Current...
Brian Freitas
Follow
586 Views
Share
First
Previous
1
2
3
4
5
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x